MicroEnvironment Tumor Effects of Radiotherapy Center
(METEOR)
Despite more than half of all cancer patients receiving radiotherapy as part of their treatment, the complex interactions between radiation and the immune system are poorly understood. The MicroEnvironment Tumor Effects of Radiotherapy (METEOR Center) is a NIH/NCI Radiation Oncology-Biology Integration Network (ROBIN) U54 grant supported initiative to improve understanding of radiation effects on the immune system and use that knowledge to propose new radiation treatment combinations to improve the outcomes of patients with advanced cancer. We will bring together a diverse group of experts from many fields, while teaching the next generation of researchers and engaging with other ROBIN Network Centers.
WE ARE A MEMBER OF:
More about the ROBIN Network
NCI-funded Radiation Oncology-Biology Integration Network (ROBIN) will work collaboratively to optimize radiation therapy in combination with anti-cancer agents.
Radiation therapy (RT) can dynamically induce molecular targets in tumors that are not seen at diagnosis. The goal of ROBIN is to learn more about this complex biology to develop better therapies for people with cancer.
Collaborating Institutions
- University of Maryland & Thomas Jefferson University – ROBIN OligoMET Center
- Weill Medical College of Cornell University, Memorial Sloan Kettering Cancer Center & University of Chicago – ROBIN ImmunoRad Center
- Cleveland Clinic Foundation & Emory University – ROBIN Gen-Rad Center
- Dana-Farber Cancer Institute – Pediatric Cancer Biology and Data Science